Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2019

Sep 12, 2019

34491_dirs_2019-09-12_391d35fc-8947-4618-bbf4-c8a1dc537bf5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-09-10

Reporting Person: JANTZ DEREK (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-10 Common Stock M 13176 $1.18 Acquired 3858346 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-10 Employee Stock Option (Right to Buy) $1.18 M 13176 Disposed 2027-03-23 Common Stock (13176) Direct

Footnotes

F1: The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month
period over the 36 months following such date.